(Q34936216)

5 August 2017

1 reference

title

Pre-emptive treatment of recurrent hepatitis C infection (English)

1 reference

5 August 2017

1 reference

Michael Charlton

1

1 reference

5 August 2017

publication date

1 October 2002

1 reference

5 August 2017

published in

Liver Transplantation

1 reference

5 August 2017

volume

8

1 reference

5 August 2017

issue

10 Suppl 1

1 reference

5 August 2017

page(s)

S50-4

1 reference

Epidemiology of hepatitis C

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Demographic determinants of hepatitis C virus seroprevalence among blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Recurrent and new hepatitis C virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Long-term outcome of hepatitis C infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Causes of graft loss following liver transplantation for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Predictors of patient and graft survival following liver transplantation for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

The association between hepatitis C infection and survival after orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

The influence of hepatitis C virus genotypes on the outcome of liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Reinfection of liver graft by hepatitis C virus after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Graft loss following liver transplantation in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Interferon-alpha therapy for hepatitis C virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Combination of interferon induction therapy and ribavirin in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Treatment of acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Treatment of acute hepatitis C with interferon alfa-2b

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Successful rescue of severe recurrent hepatitis C with interferon and ribavirin in a liver transplant patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.35859

21 January 2018

Identifiers

DOI

10.1053/JLTS.2002.35859

1 reference

5 August 2017

1 reference